Water Island Capital’s Aerie Pharmaceuticals AERI Stock Holding History

Water Island Capital’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,082,516	Closed	-$31.5M	–	106
2022 Q3	$31.5M	Buy	+2,082,516	New	+$24.2M	1.78%	28

Water Island Capital's AERI Position: Q4 2022 in Review

Water Island Capital sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 2,082,516 shares — an estimated $31.5M sold.

Water Island Capital first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $31.5M in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Water Island Capital reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Water Island Capital sold 2,082,516 Aerie Pharmaceuticals shares in Q4 2022, an estimated $31.5M.
Water Island Capital first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
Water Island Capital's Aerie Pharmaceuticals position peaked at $31.5M in Q3 2022.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Water Island Capital's 13F filing for Q4 2022, filed 14 Feb 2023.